Keyphrases
Exosomes
84%
Stem Cells
77%
Heart Failure
53%
Regenerative Medicine
46%
Cell-based
41%
Stem Cell Therapy
41%
Embryonic Stem Cells
39%
Clinical Trials
33%
Cardiopoiesis
33%
Cardiopoietic Stem Cells
31%
Continuous-flow Left Ventricular Assist Device (CF-LVAD)
30%
Mesenchymal Stem Cells
29%
Human Mesenchymal Stem Cells (hMSCs)
27%
Cell Therapy
26%
Human Platelet Extract
25%
Myocardial Infarction
22%
Left Ventricular Assist Device
22%
Ischemic Heart Failure
21%
Myocardium
21%
Platelets
21%
Left Ventricular Assist Device Implantation
19%
Regeneration
18%
Confidence Interval
18%
Cardiogenesis
17%
Left Ventricular Assist Device Therapy
17%
Femoral Head Osteonecrosis
16%
Acute Myocardial Infarction
16%
Corticosteroids
16%
Porcine
16%
Cardiac Repair
16%
Right Heart Catheterization
15%
Secretome
15%
Patient Demographics
15%
Right Ventricular Function
14%
KATP Channel
14%
Kir6.2
13%
Heart Repair
13%
Left Heart Catheterization
13%
Hazard Ratio
13%
Congestive Heart Failure
13%
Cardiomyocytes
12%
Intra-aortic Balloon Pump
12%
Left Ventricular Assist Device Support
12%
Catheter
12%
Cardiomyopathy
12%
Porcine Model
11%
Platelet-rich Plasma
11%
Cardiac Differentiation
11%
Percutaneous Coronary Intervention
11%
Heart Transplant Recipients
11%
Medicine and Dentistry
Congestive Heart Failure
100%
Stem Cell
90%
Exosome
79%
Left Ventricular Assist Device
69%
Platelet
43%
Stem Cell Therapy
38%
Hemodynamic
29%
Clinical Trial
29%
Medicine
28%
Mesenchymal Stem Cell
26%
Cardiac Catheterization
26%
Cell Therapy
25%
Myocardium
24%
Regeneration
23%
Myocardial Infarction
22%
Device Therapy
20%
Heart Muscle Ischemia
19%
Intra-Aortic Balloon Pump
18%
Heart Graft
18%
In Vitro
17%
Diseases
16%
Myocardial Disease
16%
Cardiac Muscle Cell
16%
Rejuvenation
14%
Kir6.2
13%
Tissue Regeneration
13%
Acute Heart Infarction
12%
Adenosine Triphosphate
12%
Patient Population
12%
Heart Transplantation
11%
Hazard Ratio
11%
Cell Proliferation
11%
Potassium Channel
11%
Gene Targeting
11%
Adipose-Derived Mesenchymal Stem Cell
10%
Wound Healing
10%
Skeletal Muscle
10%
Adult Stem Cell
9%
Ischemic Cardiomyopathy
9%
Adenosine Triphosphate Sensitive Potassium Channel
9%
Thrombocyte Rich Plasma
9%
Cytotechnology
9%
Adipose Tissue
9%
Embryonic Stem Cell
9%
Osteonecrosis Of The Femoral Head
8%
Ejection Fraction
8%
Ischemic Heart Disease
8%
Fibrin Glue
8%
Quality of Life
8%
Pulmonary Hypertension
7%